POSITION SUMMARY: The MSL, Oncology will join a fast-growing Field Medical Affairs team that is focused on commercializing the novel Signatera™ molecular residual disease test to oncologists and cancer researchers, along with complementary products and services in Natera’s oncology portfolio. In 2019, the FDA designated Signatera as a Breakthrough Device, and Medicare proposed to cover its use in patients with Stage II-III colorectal cancer as its first covered indication. We are looking for a smart, mission-oriented Medical Affairs professional who can communicate effectively and help us transform the management of cancer worldwide. The Medical Science Liaison (MSL) serves as a key field-based scientific resource for clinicians, academic instit
This job listing is no longer active.
Check the left side of the screen for similar opportunities.